Business / Industry Sectors
Life Sciences & Pharmaceutical > Healthcare
Angioslide Ltd
PROTEUS - Embolic Capture Angioplasty
Angioslide developed and markets the PROTEUS™ - Embolic Capture Angioplasty (ECA) device family, the only FDA cleared device that enables physicians to capture and remove embolic fragments dislodged at the lesion site in peripheral arteries. The PROTEUS embolic capture feature is uniquely integrated into an angioplasty balloon, providing onsite embolic removal at the point of disruption.
Contact Information
Eran Vickus
Phone no.: 972 (0)9 7904609
ad
ad
ad
ad
ad
ad